Baldeep Wirk Selected Research

Hematologic Neoplasms (Hematological Malignancy)

11/2023	Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
1/2023	Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
1/2023	Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
8/2012	Early Recognition of Immune Reconstitution Inflammatory Syndrome Leads to Avoidance of Endotracheal Intubation.
12/2009	Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baldeep Wirk Research Topics

Disease

13	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2023 - 10/2015
11	Neoplasms (Cancer) 11/2023 - 01/2010
11	Multiple Myeloma 01/2023 - 08/2011
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 05/2013
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 08/2012
6	Leukemia 01/2020 - 05/2013
5	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2009
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 01/2018
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 05/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 03/2015
4	Infections 01/2021 - 01/2016
4	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2010
3	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 01/2014
3	Invasive Fungal Infections 01/2023 - 11/2008
3	Mycoses (Diseases, Fungus) 01/2023 - 01/2011
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2015 - 05/2013
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 07/2017
2	Hemorrhage 01/2022 - 12/2012
2	Bronchiolitis Obliterans Syndrome 01/2021 - 10/2015
2	Amyloidosis 07/2017 - 11/2015
2	Aplastic Anemia (Anemia, Hypoplastic) 05/2016 - 10/2015
2	Lymphoma (Lymphomas) 10/2015 - 09/2015
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 04/2013
2	Bone Marrow Failure Disorders 10/2015 - 05/2013
2	Fanconi Anemia (Fanconi's Anemia) 10/2015 - 05/2013
2	Breast Neoplasms (Breast Cancer) 01/2006 - 11/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Clostridium Infections 01/2023
1	Obesity 01/2023
1	Central Nervous System Neoplasms 01/2023
1	Chronic Renal Insufficiency 01/2023
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Cryptogenic Organizing Pneumonia 01/2022
1	Acute Disease 01/2021
1	Blast Crisis (Blast Phase) 10/2020
1	Pathologic Complete Response 01/2020
1	Thrombotic Microangiopathies 01/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013
1	Essential Thrombocythemia 09/2012
1	Splenomegaly 09/2012
1	Polycythemia Vera 09/2012
1	Neutropenia 08/2012
1	Immune Reconstitution Inflammatory Syndrome 08/2012

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 12/2013
5	Busulfan (Busulfex)FDA Link 07/2023 - 12/2013
4	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2020
4	fludarabineIBA 07/2023 - 01/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2019
2	Alemtuzumab (Campath)FDA Link 01/2020 - 01/2019
2	AntigensIBA 01/2019 - 08/2012
2	Methotrexate (Mexate)FDA LinkGeneric 08/2017 - 10/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 12/2013
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	lorlatinibIBA 01/2023
1	Proteasome InhibitorsIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	CI 22IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	SteroidsIBA 10/2018
1	Calcineurin InhibitorsIBA 08/2017
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2017
1	ApolipoproteinsIBA 07/2017
1	Prealbumin (Transthyretin)IBA 07/2017
1	Amyloid (Amyloid Fibrils)IBA 07/2017
1	AA amyloidosisIBA 07/2017
1	Congo RedIBA 07/2017
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Rituximab (Mabthera)FDA Link 11/2014
1	Bortezomib (Velcade)FDA Link 12/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2012

Therapy/Procedure

50	Cell Transplantation 11/2023 - 08/2011
18	Transplantation 11/2023 - 08/2011
14	Therapeutics 01/2023 - 11/2005
8	Drug Therapy (Chemotherapy) 11/2023 - 11/2005
8	Hematopoietic Stem Cell Transplantation 01/2023 - 12/2009
7	Autologous Transplantation 01/2023 - 11/2013
7	Homologous Transplantation 01/2021 - 02/2013
3	Stem Cell Transplantation 01/2023 - 08/2011
2	Immunotherapy 01/2023 - 11/2014
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2023
2	Activities of Daily Living (ADL) 01/2019 - 01/2019
1	Resistance Training 01/2023
1	Donor Selection 03/2022
1	MDC protocol 01/2022
1	Salvage Therapy 01/2022
1	Secondary Prevention 11/2013
1	Splenectomy 09/2012